Related Experiment Videos
[Distraction osteogenesis in a newborn infant with Pierre-Robin sequence]
S Villani1, B Brevi, E Sesenna
1Dienst für Zahn-, Mund- und Kieferheilkunde, Krankenhaus Bruneck, 39031 Bruneck BZ, Italien. sandro.villani@as-brunico.it
Mund-, Kiefer- Und Gesichtschirurgie : MKG
|July 30, 2002
Summary
A new extraoral distractor for Pierre Robin sequence in newborns offers a promising solution. This innovative device reduces scarring and complications, improving outcomes for infants with this condition.
Area of Science:
- Craniofacial surgery
- Pediatric surgery
- Biomedical engineering
Background:
- Pierre Robin sequence (PRS) prognosis is often linked to asphyxia and cerebral damage.
- Traditional PRS treatments present challenges and require long-term care.
- Distraction osteogenesis is a promising PRS treatment, especially for newborns.
Observation:
- A novel extraoral distractor was developed for newborns up to 3 months old.
- Two infants, aged 2 and 3 months, were treated with this new device.
- The distractor was specifically designed by the department for neonatal application.
Findings:
- Successful airway management was achieved in both cases, with extubation on postoperative days 7 and 20.
- Significant mandibular length gain was observed: 20 mm in the first case and 15 mm in the second.
- The new distractor minimized pin-related complications and scarring.
Implications:
- This novel extraoral distractor offers a safer and more effective treatment for PRS in newborns.
- Reduced scarring and fewer complications can lead to improved long-term aesthetics and function.
- The device's design addresses limitations of traditional distraction osteogenesis in infants.